EUVIMEDEUVIMED entdecken
Open Access

Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health

Esteban Zavaleta-Monestel iD, Sebastián Arguedas-Chacón iD, Jeaustin Mora-Jiménez iD, Carlos Wu-Chin, Roberto Rodríguez-Miranda iD

Pharmacoepidemiology and Drug Safety · 2026-07 · 35 (7)

DOI: 10.1002/pds.70421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 28.06.2026. Verfasst von Esteban Zavaleta-Monestel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Research Department, Clínica Bíblica, San José, Costa Rica. Hauptthemen laut MEDLINE: Analgesics, Opioid, Public Health, Drug and Narcotic Control, Practice Patterns, Physicians'. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The global opioid crisis has highlighted substantial differences in prescribing, monitoring, and regulatory practices across health systems. In Costa Rica, comprehensive national data on opioid use have been limited. This study aimed to describe temporal trends in legally prescribed opioid consumption between 2017 and 2024 using nationwide administrative data.

Methods

A nationwide, retrospective, population‐based analysis was conducted using data from the Costa Rican Ministry of Health's narcotics registry. Dispensation records for morphine, methadone, fentanyl, oxycodone, and tapentadol were included. Opioid consumption was standardized to Morphine Milligram Equivalents (MME) using NIH HEAL conversion factors. Temporal trends were assessed using descriptive statistics and simple linear regression.

Results

A total of 31.9 million opioid dispensations were recorded during the study period. National opioid consumption peaked in 2018 (395.1 million MME), followed by an approximate 70% decline through 2023 and a modest increase in 2024. Consumption of morphine and methadone declined substantially (−72.2% and −82.4%, respectively), while oxycodone and tapentadol showed moderate increases over time. These findings indicate a marked reduction in overall opioid consumption alongside changes in the distribution of use across opioid agents.

Conclusions

Between 2017 and 2024, Costa Rica experienced a sustained decline in total opioid dispensing and a redistribution of opioid use across substances. These trends occurred in the context of strengthened regulatory oversight and expanded digital monitoring of controlled substances. While causal relationships cannot be established, the findings provide relevant population‐level evidence to support opioid stewardship and inform regulatory and public health strategies in middle‐income health systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidPublic HealthDrug and Narcotic ControlPractice Patterns, Physicians'Costa RicaHumansRetrospective StudiesRegistries

Stichwörter der Autor:innen

Costa RicaPharmacoepidemiologydigital prescription systemmorphine milligram equivalentsopioidspharmacovigilancepublic healthregulatory policy

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Health Research Department, Clínica Bíblica, San José, Costa Rica.
  • Pharmacy Department, Clínica Bíblica, San José, Costa Rica.
  • Department of Critical Care Medicine, Clínica Bíblica, San José, Costa Rica.
  • Anesthesiology and Pain Clinic Service, Clínica Bíblica, San José, Costa Rica.

ORCID-Profile: Esteban Zavaleta-Monestel, Sebastián Arguedas-Chacón, Jeaustin Mora-Jiménez, Roberto Rodríguez-Miranda

Zitieren

APA

Zavaleta-Monestel, E., Arguedas-Chacón, S., Mora-Jiménez, J., Wu-Chin, C., & Rodríguez-Miranda, R. (2026). Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health. Pharmacoepidemiology and Drug Safety, 35(7). https://doi.org/10.1002/pds.70421

Vancouver

Zavaleta-Monestel E, Arguedas-Chacón S, Mora-Jiménez J, Wu-Chin C, Rodríguez-Miranda R. Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health. Pharmacoepidemiology and Drug Safety. 2026;35(7). doi:10.1002/pds.70421

BibTeX
@article{ZavaletaMonestel2026,
  author = {Zavaleta-Monestel, Esteban and Arguedas-Chacón, Sebastián and Mora-Jiménez, Jeaustin and Wu-Chin, Carlos and Rodríguez-Miranda, Roberto},
  title = {Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {7},
  doi = {10.1002/pds.70421}
}
Kostenlos starten →